Itsuro Shimada

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

Masamichi Mori, Naoki Kaneko, Yoko Ueno et al. · Investigational New Drugs · 2017 · 249 citations · Full text

The Selective Anaplastic Lymphoma Receptor Tyrosine Kinase Inhibitor ASP3026 Induces Tumor Regression and Prolongs Survival in Non–Small Cell Lung Cancer Model Mice

Masamichi Mori, Yoko Ueno, Satoshi Konagai et al. · Molecular Cancer Therapeutics · 2014 · 57 citations · Full text

Eml4 Genes, Immunology, Cancer Biology +16

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist

Yasuharu Kimura, Ken-ichi Hatanaka, Yuki Naitou et al. · European Journal of Pharmacology · 2003 · 52 citations · Full text

Biochemistry, Functional Selectivity, Medicine +5

Synthesis and Biological Evaluation of 3-Biphenyl-4-yl-4-phenyl-4<i>H</i>-1,2,4-triazoles as Novel Glycine Transporter 1 Inhibitors

Takashi Sugane, Takahiko Tobe, Wataru Hamaguchi et al. · Journal of Medicinal Chemistry · 2010 · 43 citations · Full text

Pharmaceutical Science, Immunology, Pharmacotherapy +16

Synthesis and structure–activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists

Itsuro Shimada, Kyoichi Maeno, Kenichi Kazuta et al. · Bioorganic & Medicinal Chemistry · 2007 · 35 citations · Full text

Molecular Pharmacology, Medicine, 5-Ht2c Receptor Agonists +6